• Home
  • Ministers
  • For Consumers
    • Aboriginal and Torres Strait Islander Health
    • Conditions and Diseases
    • Education and Prevention
    • Ethical Issues
    • Gene Technology
    • Health Care Homes
    • Health products and medicines
    • Public and private healthcare
    • Industrial chemicals
    • Medicare
    • Mental Health
    • National Men's and Women's Health
    • National Rural Health Commissioner
    • Norfolk Island
    • Palliative Care
    • Pharmacy
    • Primary Care
    • Regulation and Red Tape Reduction
    • Rural and Regional Health
    • Services
    • Healthier Medicare
    • Travel Health Information
  • For Health Professionals
    • Aboriginal and Torres Strait Islander Health
    • Conditions and Diseases
    • Education and Prevention
    • Ethical Issues
    • Gene Technology
    • Genomics
    • Health Provider Compliance
    • Health products and medicines
    • Health Thesaurus
    • Health Workforce
    • Public and private healthcare
    • Healthier Medicare
    • Medicare
    • My Health Record
    • National Men's and Women's Health
    • Palliative Care
    • PBS Approved Suppliers
    • Regulation and Red Tape Reduction
    • Rural and Regional Health
    • Services
    • A Strong and Sustainable Medicare
    • Travel Health Information
  • About us
  • Media Centre
  • Programs & Campaigns
    • Agreements
    • Awards
    • eHealth
    • Programs & Initiatives
    • Campaign Certification Statements
  • Resources
    • Publications
    • Research & Statistics
    • CurrentIssues
  • Ageing & Aged Care
  • You are here:
  • Home /
  • Resources /
  • Publications /
  • Historical publications /

Teriparatide Independent Review

Appendix 1

Page last updated: 02 March 2007

Figure 1.0 - Flow diagram of basic steps in development of health-state utility measurements.

Source: Furlong et al (1990)


Top of page

  • previous page
Listen
  • Table of contents
  • Executive Summary
  • Scope for review of Teriparatide submissions
  • Description of Review Process
  • Matter 1 - Indirect data comparison and subgroup analysis
    • 1 (A) Validity of indirect comparison
    • 1 (B) Validity of subgroup analysis in pivotal study
  • Matter 2 - Biological Plausibility
  • Matter 3 - Validity of continued use of utilities
  • Key References
  • Appendix 1

Document download

This publication is available as a downloadable document.

Teriparatide Independent Review (PDF 263 KB)

Popular

    • Feedback
    Provide feedbackIf you would like a response please complete our enquiries form.


    Comments will be used to improve web content and will not be responded to.

    Real person check

    This form uses a CAPTCHA to ensure that it is submitted by a person, instead of a machine or automated software.


    Privacy statement

    Your feedback has been submitted

    Thank you for taking the time to provide feedback. It will be used to make improvements to this website.